| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |